ArticleCurrent neuropharmacology2025
Age-Dependent Correlation between Immune Parameters and Symptoms in Young Adults with Schizophrenia.
Article in Current neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heterogeneity of composite inflammatory markers in acute schizophrenia: stratification by age, gender, and age at onset.European archives of psychiatry and clinical neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSchizophrenia (SCZ) is a debilitating mental disorder of unknown etiology. It is characterized by both positive and negative symptoms. Increasing evidence reports the role of immune abnormalities in the pathogenesis of SCZ.
objectiveThis study aimed to examine the potential effect of age on the associations between clinical symptoms and immune parameters in drug-naïve first episode SCZ (DNFES).
methodsA total of 64 young DNFES patients were recruited and divided into younger and older groups according to the median age. Immune parameters, including neutrophil (NEU), lymphocyte (LYM), and neutrophil-to-lymphocyte ratio (NLR) values, were measured and compared between the younger and older patients to investigate the potential effect of age on the correlations between immune parameters and clinical symptoms.
resultsWe found that NEU and NLR were significantly higher in patients compared to healthy controls, with even higher values observed in the younger group than in the older group. In addition, NEU count was correlated with clinical symptoms in older patients, while NLR was correlated with symptoms in younger patients. Linear regression analysis showed that NEU or NLR values were associated with the clinical symptoms in patients with SCZ after controlling confounders.
conclusionOur study suggests that young adult patients had abnormal immune parameters. Furthermore, age mediated the relationships between immune parameters and symptom severity. This study provides further evidence that abnormal immune parameters, particularly an increased innate immune response, may be involved in the pathophysiology of SCZ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.